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IntroDuctIon
Non-opsin optogenetic tools allow light-control of a variety of 
biological processes in cells and in whole organisms1,2. Most of the 
developed optogenetic tools are operated by a single wavelength, 
and hence enable control of a single cellular event, such as pro-
moting gene transcription or activation of a signaling pathway3,4. 
However, the majority of physiological processes are controlled 
by multifunctional regulatory molecules or their ensembles. 
Thus, optogenetic tools for spectral multiplexing are required to 
increase the complexity of light-driven manipulations. Here, we 
present a protocol for our recently developed approach for gene 
transcription activation with a NIR (740–780 nm) light-sensing 
optogenetic system based on a bacterial phytochrome from 
Rhodopseudomonas palustris (RpBphP1; hereafter BphP1) and 
its engineered protein partner QPAS1 (ref. 5). This protocol 
allows multiplexing of the BphP1–QPAS1 system with blue-light- 
controllable tools with minimal spectral crosstalk. We also provide 
a protocol for manipulation of the intracellular protein localization 
independently controlled by blue and NIR light.
Development of the protocol
Protein–protein interactions (PPIs) have a crucial role in cellular 
functions and biological processes in all organisms. Control of PPIs 
by light should promote the progress of basic biology and biomed-
icine due to noninvasiveness, adjustability, high spatiotemporal 
resolution and potential for multiplexing. Natural diversity of light-
sensing photoreceptors allowed the development of a series of effec-
tive tools for regulation of cell functions by light6. Among them, the 
tools based on bacterial phytochromes were shown to be beneficial 
for use in mammalian cells and whole animals. This is because bac-
terial phytochromes use biliverdin IXα (BV), which is a ubiquitous 
heme derivative present in mammalian cells, as a chromophore7–9 
and are naturally sensitive to far-red and NIR light, which penetrates 
deep into mammalian tissues through the so-called tissue transpar-
ency window between 650 and 900 nm (refs. 10,11).
The first BphP1-based optogenetic system for a light- 
controllable PPI was designed using its full-length natural bind-
ing partner RpPpsR2 (hereafter referred to as PpsR2)4. BphP1 
is a light-sensing component of the BphP1–PpsR2 optogenetic 
system and adopts the Pfr state, absorbing at 760 nm in the 
dark. Under NIR light of 740–780 nm, it undergoes photocon-
version into the Pr state, absorbing at 680 nm and resulting in 
the binding of PpsR2. This light-controllable reversible PPI was 
successfully used to regulate cell signaling and gene transcription 
in cultured cells and in mice4. At this stage, it was shown that 
prolonged expression of BphP1 in mammalian cells allows usage 
of the system without the requirement for exogenous BV.
Further improvement in the BphP1 system led to the devel-
opment of an engineered PpsR2 variant, called QPAS1, which 
is threefold smaller than the natural protein and lacks domains 
potentially involved in its oligomerization. The resulting BphP1–
QPAS1 system was used for both transcription activation and 
transcription inhibition by NIR light. Moreover, the interaction 
of BphP1 and QPAS1 was used for light-induced intracellular 
protein relocalization. Detailed analysis of the spectral behavior 
of the BphP1-based tools revealed negligible cross-activation with 
common GFP-like fluorescent proteins. More importantly, this 
also facilitates spectral multiplexing with blue-light-activatable 
optogenetic constructs, thereby allowing for fast, revers-
ible, two-color-controlled protein targeting in cells. We have 
recently combined the BphP1–QPAS1 tool with an optogenetic 
tool based on a LOV domain from Avena sativa phototropin-1 
(hereafter AsLOV2), in which the caged nuclear localization signal 
(cNLS) is uncaged in response to 460-nm light5. In this protocol, 
we describe two multiplexing approaches for light-controlled 
transcription activation and protein targeting. In the first, gene 
expression is activated in mammalian cells in response to NIR 
and blue light with negligible spectral crosstalk. In the second 
approach, the protein of interest is actively relocalized from the 
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near-infrared (nIr, 740–780 nm) optogenetic systems are well-suited to spectral multiplexing with blue-light-controlled tools.  
Here, we present two protocols, one for regulation of gene transcription and another for control of protein localization, that use a  
nIr-responsive bacterial phytochrome Bphp1–Qpas1 optogenetic pair. In the first protocol, cells are transfected with the 
optogenetic constructs for independently controlling gene transcription by nIr (Bphp1–Qpas1) and blue (lighton) light. the 
nIr and blue-light-controlled gene transcription systems show minimal spectral crosstalk and induce a 35- to 40-fold increase in 
reporter gene expression. In the second protocol, the Bphp1–Qpas1 pair is combined with a light-oxygen-voltage-sensing (loV) 
domain-based construct into a single optogenetic tool, termed irIs. this dual-light-controllable protein localization tool allows 
tridirectional protein translocation among the cytoplasm, nucleus and plasma membrane. Both procedures can be performed within 
3–5 d. use of nIr light–controlled optogenetic systems should advance basic and biomedical research.
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cytoplasm to either the plasma membrane or the nucleus, being 
independently controlled by two distinct colors.
Applications of the method 
Spatiotemporal optogenetic control of biochemical processes in 
cells and animals can advance basic biology and biomedicine. An 
important venue of optogenetic manipulation is the modulation 
of cellular PPIs to control various cellular processes. NIR-light-
controlled tools may be applied to activate almost any physiologi-
cal process dependent on PPIs.
Genetically encoded optogenetic NIR-light-dependent systems 
exhibit several advantages over pharmacologically inducible PPI 
approaches; these include noninvasiveness, high PPI activation 
rates, fast reversibility and lack of potential side effects of drugs. 
These systems can be used not only in cell culture but also in 
animals for controlling intracellular protein localization, induc-
tion of enzymatic activity and activation of gene expression4. 
The BphP-based transcription regulation systems are compatible 
with reporter systems based on a Tet response element (TRE) 
and a Gal4 upstream activation sequence (UAS). These reporter 
systems are the most popular for conditional transcription 
activation in animals and, consequently, various Tet- and Gal4-
responder animal lines (including fruit flies, zebrafish and mice) 
are available12–14, which potentially allows wide application of the 
BphP1-based transcription activation in animals.
Beyond proof-of-principle applications, non-opsin optogenetic 
systems have been proven useful for controlling the physiology of 
various invertebrate15,16 and vertebrate organisms4,17,18. Among 
biological processes, cell differentiation and reprogramming 
were light-regulated to achieve tissue modeling19. These types 
of applications can benefit greatly from multiplexing with vis-
ible-light tools, potentially allowing more-complex differentia-
tion scenarios. Indeed, cellular differentiation processes during 
development are usually guided by transcription factor ensembles 
rather than single triggering molecules. Although complex gene 
networks were modeled in bacteria20, substantially fewer multi-
plexing approaches are known for mammalian cells21,22, making 
BphP1–QPAS1-based systems beneficial for multicolor control of 
cell differentiation. Unlike the original PpsR2, the smaller QPAS1 
in the BphP1–QPAS1 pair is expected to be preferable in cer-
tain size-limited gene-delivery systems, such as adeno-associated 
viruses. Such virus-mediated delivery is hardly possible for larger 
light-sensitive proteins such as GIGANTEA23 or PhyB (ref. 24), 
or those which require delivery of additional enzymes to provide 
chromophore synthesis25. Its viral gene delivery will allow use of 
the BphP1–QPAS1 pair in various difficult-to-transfect cell lines 
and in tissues of living animals, expanding its applicability.
Moreover, the smaller QPAS1 size enables combination of the 
BphP–QPAS1-based NIR-sensitive system with the AsLOV2-
based blue-light-sensitive optogenetic system. A near-IR-blue-
light-inducible shuttle (termed iRIS), based on QPAS1 (NIR) and 
LOV (blue), allows researchers to target proteins to the nucleus 
with blue light (460 nm), to the plasma membrane with NIR light 
and to the cytoplasm in the dark. Among other possible applica-
tions, the iRIS could also be used for more stringent regulation 
of protein localization. For example, a transcription factor could 
be caged at the plasma membrane using the iRIS. This caging 
could act synergistically with a nuclear exclusion signal (NES) 
to additionally reduce the background activity of a transcription 
factor in the nucleus. In this case, activation of the transcription 
factor would require two triggers, dark relaxation of BphP1 for 
uncaging from the membrane and blue light for active nuclear 
transport, providing more stringent control. In applications in 
which protein activity or protein signaling depends on its localiza-
tion, the iRIS creates new approaches to study functions of sign-
aling molecules in specific subcellular environments. Instead of 
the membrane-localization peptide sequence in the current iRIS 
variant, various protein-targeting signals could be used to target 
a protein of interest to different organelles or allow its secretion. 
As bacterial phytochrome-based and LOV-based optogenetic 
tools have been used separately in non-mammalian model ani-
mals15,26–28, we anticipate that the iRIS-based approach can be 
applied in various model animals. Activation of the BphP1 part 
of the system can be done with NIR light, whereas activation of 
the LOV part of the system can be done with 460-nm blue light 
or 900-nm light in two-photon mode.
Similar to other light-sensitive proteins used for optogenetic 
tool development, the BphP1–QPAS1 pair can be further modi-
fied using protein-engineering techniques1,29,30. Potential proper-
ties to modify include the BV binding rate (to avoid uncontrolled 
interaction with QPAS1), background QPAS1 interaction in the 
Pfr state, the kinetics of BphP1 photoconversion and the stability 
of the Pr and Pfr states. For the last, experimental data from the 
area of bacterial phytochrome-based NIR fluorescent proteins can 
be used for structure-guided rational design31,32.
Comparison with other methods 
Many systems using small molecules to control PPIs share com-
mon drawbacks. Among these drawbacks are the lack of tempo-
ral and spatial precision, potential side effects of the activating 
drugs33, slow pharmacokinetics and large consumption of expen-
sive compounds. Some systems are also reported to be leaky or 
to demand more-specific reagents34,35. Optogenetic systems lack 
these drawbacks, and inexpensive, widely available LED emitters 
allow easy custom assembly of low-voltage light sources for illu-
mination in any spectral range, from UV to IR.
Optogenetic tools developed from bacterial phytochromes 
possess several advantages over other light-controlled systems. 
First, the BV availability in mammalian cells and tissues makes 
the application of the bacterial phytochrome-based systems inde-
pendent of exogenously supplied chromophores, whereas plant 
phytochrome-derived constructs, such as those based on PhyB, 
although exploited in a wide range of light-controlled applica-
tions24,36, require the phycocyanobilin compound as a chromo-
phore. This compound is not available in eukaryotic cells and 
should be delivered exogenously or synthesized intracellularly by 
overexpressing several bacterial enzymes25,37, potentially incur-
ring cytotoxicity and other side effects.
Second, bacterial phytochrome–based tools are sensitive to NIR 
light, which has a higher penetration depth by virtue of low light 
absorption and scattering of 650- to 800-nm light by mammalian 
tissues (Supplementary Fig. 1). By contrast, blue-light-control-
led tools require much higher light intensities, when applied to 
animal models, to achieve light-activation in deep tissues3. It is 
also known that the plant phytochrome-based tools are extremely 
sensitive to far-red light (660 nm)37. Moderate sensitivity to light 
and reversibility of BphP1 activation make the BphP1-based tools 
tolerate low-level ambient light, which makes them easier to work 
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with in an experimental setting. BphP1-based tools are also non-
sensitive to illumination from conventional light sources with an 
emission peak in the blue–yellow spectral range. However, some 
precautions with broadband and blue-light sources are required 
because a partial BphP1 activation through its Soret absorption 
band, which peaks at 390–420 nm, may occur.
These properties of optogenetic tools based on bacterial phy-
tochromes make them more valuable when combined with other 
light-sensitive constructs. In this regard, AsLOV2-based tools 
for protein targeting28,38–40 using the peptide caging–uncaging 
principle are perfect for this combination. Until now, all pro-
tein-targeting optogenetic systems could either direct a protein 
of interest from the cytosol to a single specific compartment (e.g., 
plasma membrane, mitochondria, nucleus and peroxisomes) or 
translocate it between two different locations (e.g., nucleus and 
mitochondria). In this protocol, the two-color-controllable tool 
iRIS, which uses the AsLOV2 domain, provides tridirectional 
protein targeting, which is not possible with optogenetic tools of 
monochromatic light.
Limitations 
Despite successful use of the BphP1–QPAS1 pair for light-con-
trol of cellular processes, there are several factors that currently 
narrow its applications. Most of the limitations are shared with 
similar systems, which use light or drugs to control PPIs.
One potentially limiting feature of the bacterial phytochrome-
based tools is dependence on cellular BV, which was shown to 
vary depending on the particular tissue or cell type9. As the 
BphP1 apoprotein likely can also interact with PpsR2 in a light-
independent way41, high BphP1 concentrations and a shortage 
of BV may lead to undesired PPIs in the dark, reducing the light-
to-dark signal contrast. This may become especially critical for 
applications in which absolute signal values are sometimes hard 
to compare or estimate correctly, and it can be a limiting step, in 
particular for applications that are sensitive to the background 
level in the dark.
However, in cell culture, this can be overcome by the generation 
of a stable cell line with low expression of the BphP1 component 
(see Box 1 for detailed procedures). Applicability of the BphP1–
QPAS1 systems in vivo in tissues with low BV levels, such as neural 
tissues, must be tested. However, successful visualization of NIR 
fluorescent proteins incorporating BV as a chromophore in neu-
rons and in the mouse brain42 provides reasons for optimism.
Another difficulty with the BphP1–QPAS1 pair is its relatively 
slow kinetics of thermal relaxation (deactivation) as compared 
with similar systems. Moreover, the level and kinetics of the 
cellular response to NIR illumination may depend not only on 
the well-characterized light-controlled PPI between BphP1 and 
QPAS1 (refs. 4,5), but also on the characteristics of DNA-binding 
domains (Gal4 and TetR), transcription regulation modules (VP16 
and SID) and the protein-targeting peptide signals (NLS, NES and 
CAAX) used. Similarly, the output signal values in transcription 
activation, as well as background signals in protein targeting, are 
strongly influenced by the expression levels of all components 
of the system. Thus, pilot studies to determine BV dependence 
and appropriate expression schemes are unavoidable when 
Box 1 | Generation of a cell line stably expressing the BphP1 component of 
the optogenetic system ● tIMInG 6 weeks 
BV is an essential factor for the correct functioning of bacterial phytochrome–based optogenetic systems. In mammalian cells,  
BV exists in equilibrium with bilirubin, and these together act as a part of the protective system against cellular stress49. Endogenous 
BV levels are usually sufficient in experiments with bacterial phytochrome expression over prolonged times4,50. However, if delivered 
using transient transfection, the high level of BphP1 expression may require additional BV, which can be supplemented exogenously. 
Alternatively, a cell line stably expressing BphP1 can be generated to bypass the need for exogenous BV supplementation.
The efficiency of stable cell-line generation can be substantially increased by using a transposase system such as Sleeping Beauty45. 
Transposases facilitate the integration of the intact nucleotide sequence of interest into the genome by using a cut-and-paste  
mechanism. To do so, the BphP1–mCherry–TetR encoding cassette is placed between terminal repeats, which are recognized by  
the Sleeping Beauty transposase (pT2/SVNeo-103, see table 1). Cells are cotransfected with plasmid pT2/SVNeo-103 and the 
pCMV(CAT)T7-SB100 transposase-producing plasmid (table 1).
procedure
1. Seed 4 × 105 HeLa cells in 3 ml of DMEM supplemented with 10% (vol/vol) FBS and 1% (vol/vol) penicillin–streptomycin in a  
60-mm culture dish. Let the cells adhere overnight.
2. The next day, cotransfect the cells with pT2/SVNeo-103 and pCMV(CAT)T7-SB100 plasmids using Effectene transfection reagent as 
follows: mix 900 ng of pT2/SVNeo-103 and 100 ng of pCMV(CAT)T7-SB100 plasmids with the DNA-condensation buffer EC, to a total 
volume of 150 µl. Add 8 µl of enhancer and mix by vortexing for 1 s. Incubate at room temperature for 2–5 min.
 crItIcal step To avoid toxic effects after transfection, use endotoxin-free quality plasmid DNA purification kits.
3. Add 25 µl of Effectene transfection reagent to the DNA-enhancer mixture. Mix the samples by vortexing for 10 s. Incubate the  
samples for 5 min at room temperature for transfection-complex formation.
4. While complex formation takes place, aspirate the medium from the 60-mm culture dish with cells, wash the cells once with 3 ml of 
PBS and add 4 ml of DMEM medium supplemented with 10% (vol/vol) FBS and 1% (vol/vol) penicillin–streptomycin to the cells.
5. Add 1 ml of DMEM media supplemented with 10% (vol/vol) FBS and 1% (vol/vol) penicillin–streptomycin to the tube containing 
the transfection complexes, and mix by pipetting. Add the transfection complexes dropwise to the cells in the culture dish, and gently 
shake the dish to ensure uniform distribution of the transfection complexes.
6. 14–16 h after incubation with the transfection complex, replace the transfection complex with DMEM supplemented with  
10% (vol/vol) FBS and 1% (vol/vol) penicillin–streptomycin.
(continued)
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developing new applications or applying existing tools to specific 
biological problems.
Experimental design
This protocol is designed to control gene expression or the cellular 
localization of a protein of interest with NIR and blue light in 
cultured mammalian cells. For controlling gene expression (Fig. 1a), 
the cells are transfected with constructs carrying the BphP1-
based light-controlled transcription activation system (contain-
ing transactivation domain VP16 and DNA-binding domain 
Gal4, split in a way similar to yeast two-hybrid systems) and the 
gene of interest under the conditional promoter (Gal4-UAS) 
(Table 1). At the same time, the cells are also transfected with 
the blue-light-sensing LightOn transcription activation sys-
tem3, which is based on a homodimerization of the Vivid (VVD) 
domain of the LOV protein family (Fig. 1b).
Then the transfected cells are illuminated with NIR (740 nm) 
and blue (460 nm) light. Under NIR illumination, the VP16 trans-
activator and DNA-binding domain associate with each other 
and relocalize to the cell nucleus (driven by the NLS), where the 
complex binds the UAS and launches the transcription of a gene 
of interest. Independently, under blue light, Vivid forms a dimer, 
allowing Gal4-driven expression in cells expressing the LightOn 
system. Finally, the cells are analyzed for the expression level of 
the protein of interest. To achieve the best results, the ratio of 
plasmids and the transfection procedure should be optimized for 
each particular cell type. Control cells co-expressing (i) reporter 
constructs without the activator component and (ii) noncondi-
tional activator with the reporter are needed for estimation of 
reporter leakage and light-activation dynamic range.
Generation of cells stably expressing the light-sensing com-
ponent may precede the transient transfection and illumination 
Box 1 | Generation of a cell line stably expressing the BphP1 component of 
the optogenetic system ● tIMInG 6 weeks (continued)
7. After 8 h of cultivation in a tissue culture incubator, trypsinize the cells and transfer them to a 150-mm culture dish containing  
20 ml of DMEM supplemented with 10% (vol/vol) FBS and 1% (vol/vol) penicillin–streptomycin. Let the cells adhere overnight  
and replace the culture medium with 20 ml of selective medium: DMEM supplemented with 10% (vol/vol) FBS and 1% (vol/vol)  
penicillin–streptomycin and G418 active component (700 µg ml-1).
8. Change the selective medium every day until colonies appear.
 crItIcal step Carefully wash the cells with PBS when changing the selective medium, as many dead cells are expected after several 
days of cultivation with the selective medium.
9. After single colonies appear, decrease the concentration of G418 active component to 470 µg ml-1; this will result in faster  
cell growth.
10. Once the colonies have increased in size (to ~30–50 cells per colony), trypsinize the cells and transfer them to a 100-mm culture 
dish containing 10 ml of selective medium. Maintain the cells in selective medium with the concentration of G418 active  
component at 470 µg ml-1 until confluency.
11. Trypsinize the cells and transfer them to a 150-mm culture dish containing 20 ml of selective medium. Maintain the cells in  
selective medium with the concentration of G418 active component at 470 µg ml-1 until confluency.
12. The day before scheduled FACS-sorting, seed 2 × 106 nontransfected HeLa cells onto a 25-cm2 culture flask. These cells will be used 
as a negative control to discriminate mCherry-negative cells.
13. Start preparing the cells 2 h before scheduled sorting. Trypsinize the cells from the 150-mm culture dish, transfer them to a  
15-ml sterile tube, pellet the cells (180g, 7 min, 4 °C) and resuspend them in 15 ml of PBS without Ca2+ and Mg2+. Count the cells  
using a hemocytometer, pellet the cells by centrifugation at 180g for 7 min at 4 °C and resuspend the cells in PBS without Ca2+ and 
Mg2+ supplemented with 4% (vol/vol) FBS, 2 mM EDTA and 6 U µl-1 benzonase. Filter the cells through a sterile 30-µm filter and  
transfer them to a sterile FACS tube. Place the tube with cells on ice.
14. Trypsinize the nontransfected HeLa cells from the 25-cm2 culture flask and transfer them to a 15-ml tube. Pellet the cells by  
centrifugation at 180g for 7 min at 4 °C, resuspend them in 4 ml of PBS without Ca2+ and Mg2+, filter the cells through a 30-µm filter 
and transfer them to a sterile FACS tube.
15. Prepare several collection tubes with 500 µl of DMEM supplemented with 60% (vol/vol) FBS.
16. Perform FACS sorting. For this, run nontransfected cells and create a gate to select the mCherry-positive cells. Run the  
transfected cells and sort the mCherry-positive cells (supplementary Fig. 6).
17. After sorting, seed the cells into an appropriate culture dish depending on the number of sorted cells. Let the cells adhere  
overnight and replace the culture medium with selective medium.
18. Expand the cells in selective medium in a 150-mm dish. This step may take up to 2 weeks and depends on the amount of  
sorted cells.
19. To substantially enrich the population of mCherry-positive cells, repeat FACS sorting as described in steps 9–17.
20. Expand the cells in selection medium in a 150-mm dish.
21. Trypsinize the cells from the 150-mm dish, pellet the cells (180g, 7 min, 4 °C) and resuspend them in 10 ml of DMEM  
supplemented with 50% (vol/vol) FBS and 10% (vol/vol) DMSO. Put 1-ml aliquots in cryotubes and place the tubes into a freezing 
container. Incubate the container at −80 °C for 24 h, and then store the tubes in liquid nitrogen.
 pause poInt The cells can be stored in liquid nitrogen for up to several years.
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step in order to achieve light regulation without the necessity 
of exogenous BV (Box 1, Supplementary Fig. 2). This may be 
beneficial for the reproducibility, for coexpression with other 
constructs and when low expression levels of BphP1 are desir-
able. We recommend establishing stable cell lines if cells do not 
tolerate transient transfection or BV addition. Otherwise, tran-
sient transfection with additional BV in cell culture medium is, 
usually, a less laborious way to obtain meaningful results. Kinetics 
of the protein production can be studied using a secreted reporter, 
such as secreted embryonic alkaline phosphatase (SEAP) (Box 2). 
Alternatively, the cell line stably expressing BphP1 may be used 
for transcription activation in mice (Box 3).
The optogenetic system for protein targeting consists of the 
membrane-tethered BphP1 and the QPAS1–AsLOV2 fusion, 
termed iRIS (Fig. 2). Being localized mainly to the cytoplasm 
in the dark, the iRIS accumulates in the nucleus under blue 
light, due to the uncaging of the NLS in the AsLOV2 part28. NIR 
light targets the iRIS to the plasma membrane as a result of the 
BphP1–QPAS1 interaction. The tridirectional protein target-
ing can be observed in a single cell with fluorescence time-lapse 
imaging and analyzed using fluorescent signals in the cytoplasm 
and the nucleus.
NucleusNucleusCytoplasm
Transcription activation (BphP-based)a b Transcription activation (VVD-based)
BphP1 (Pfr)
NLS signal Gal4(148) QPAS1
BphP1 (Pr) VP16dNLS Monomeric
vivid
Dimerized
vivid
Gal4(65) p65
D
ar
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s
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s
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NucleusNucleus
No luciferase
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expression
TATATATA
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Figure 1 | Mode of function of the NIR- and blue-light-inducible  
transcription activation systems. (a) In the dark, the BphP1 bacterial 
phytochrome is in the Pfr state and localized in the cytoplasm. NIR light  
(740 nm) converts BphP1 to the active Pr state, which is able to bind 
QPAS1. The formed BphP1-QPAS1 complex translocates to the nucleus 
where it interacts with a reporter gene construct via its Gal4 DNA-binding 
domain. Gene transcription occurs from the minimal promoter, activated 
by the BphP1 fused to the VP16 transactivation domain with NLS deleted 
(VP16dNLS). (b) After the blue-light activation, the Vivid domains 
homodimerize and interact with a reporter gene construct via its Gal4 
domain (1–65). Transcription from the minimal promoter is activated by the 
p65 transactivation domain. a adapted from ref. 5, Nature Publishing Group.
taBle 1 | Plasmids used in the protocol.
application plasmid Description  addgene no.  reference
Transcription activation  
(two-color), Steps 3, 7A
pQP-T2A BphP1–VP16–T2A–NLS–
GAL4–QPAS1
102583  5
pGAVPO GAL4–VVD–p65 Not commercially  
availablea
 3
pFR-Luc UAS-controlled reporter 
(luciferase)
Not available from 
Addgeneb
 5
Tridirectional protein  
targeting, Steps 3, 7B
pQP-iRIS BphP1–mVenus–CAAX–
IRES2-NES–mCherry–
QPAS1–AsLOV2NLS
102584  5
Stable cell line  
generation, Box 1
pT2/SVNeo-103 RpBphP1–mCherry–TetR 79841  4
pCMV(CAT)T7-SB100 Sleeping Beauty  
100× transposase
34879  45
Kinetics of light-induced  
transcription activation, Box 2
pCMV-104 NLS–PpsR2–VP16 79842  4
pTRE-Tight-SEAP TRE-controlled reporter 
(alkaline phosphatase)
Not commercially  
availablea
 4
Light activation of gene 
expression in mice, Box 3
pCMV-104 NLS–PpsR2–VP16 79842  4
pTRE-Tight-Rluc8 TRE-controlled reporter 
(luciferase)
Not commercially  
availablea
4
aPlasmids and plasmid sequences should be requested from the corresponding authors of the respective original publications. bAvailable from Agilent Technologies, cat. no. 219050.
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Box 2 | Determination of the kinetics of light-induced transcription activa-
tion using a TetR-responsive system ● tIMInG 12 h, over 6 d 
To optimize the time of light-induced transcription activation, it is recommended to study the kinetics of protein expression in  
response to 740-nm light illumination. In this box, we describe how the expression of a reporter protein (SEAP) can be induced by 
740-nm light, and how the kinetics of expression can be monitored by detecting secreted SEAP in culture medium samples collected 
every 6–12 h after the beginning of illumination. For this, HeLa cells stably expressing BphP1–mCherry–TetR (Box 1) are cotransfected 
with pTRE-Tight-SEAP (7× tetO) reporter plasmid and the pCMV-104 plasmid, encoding the transcription activator VP16 fused with 
PpsR2 and nuclear localizing signal (table 1).
procedure
culture of Hela cells ● tIMInG 1 h, day 1
1. Start with one 80% confluent 100-mm dish containing HeLa cells stably expressing BphP1–mCherry–TetR (Box 1) grown in DMEM 
medium supplemented with 10% (vol/vol) FBS, 1% (vol/vol) penicillin–streptomycin and G418 active component (470 µg ml-1).
2. Trypsinize the cells and seed them in six wells of each of two 12-well plates at a density of 1 × 105 per well in 1 ml of DMEM  
medium supplemented with 10% (vol/vol) tetracycline-free FBS, 1% (vol/vol) penicillin–streptomycin and G418 active  
component (470 µg ml-1).
 crItIcal step It is important to use tetracycline-free FBS, as trace amounts of tetracycline may affect the efficiency of  
light-induced SEAP expression.
transfection procedure ● tIMInG 2 h, day 2
3. The next day, cotransfect cells in three wells in each plate with pCMV-104 and pTRE-Tight-SEAP, and in the other three wells with a 
mock plasmid (instead of pCMV-104) and the pTRE-Tight-SEAP plasmid with a plasmid ratio of 5:1. Cells cotransfected with the mock 
and pTRE-Tight-SEAP plasmids may be used as a control to detect the background level of SEAP expression from the pTRE-Tight-SEAP 
reporter plasmid. Prepare 300 ng of plasmid DNA mix (all the reagent amounts at this step are indicated per well) with the DNA-
condensation buffer (EC buffer), to a total volume of 75 µl. Add 2.4 µl of enhancer and mix by vortexing for 1 s. Incubate at room 
temperature for 2–5 min.
4. Add 6 µl of Effectene transfection reagent to the DNA–enhancer mixture. Mix the samples by vortexing for 10 s. Incubate the  
samples for 5 min at room temperature for transfection-complex formation.
5. While complex formation takes place, aspirate the medium from the cells, wash the cells once with 1 ml of PBS buffer and add  
800 µl of DMEM medium supplemented with 10% (vol/vol) FBS and 1% (vol/vol) penicillin–streptomycin.
6. Add to the tubes containing the transfection complexes 400 µl of DMEM medium supplemented with 10% (vol/vol) tetracycline-free 
FBS and 1% (vol/vol) penicillin–streptomycin, and mix by pipetting. Add the transfection complexes dropwise to the cells in the  
corresponding wells, and gently shake the plate to ensure uniform distribution of the transfection complexes. Transfer the dishes to a 
tissue culture incubator and protect them from light.
transcription activation ● tIMInG 1 h, days 3–5
7. After 8–12 h, replace the culture medium with pre-warmed DMEM medium supplemented with 10% (vol/vol) tetracycline-free FBS, 
1% (vol/vol) penicillin–streptomycin and G418 active component (470 µg ml-1).
8. Place one culture plate into the cell culture incubator equipped with an illumination source as described in the Equipment Setup 
section and illuminate the plate with a 740-nm LED with 0.2 mW cm−2 for up to 72 h. Keep the other plate in a separate cell culture 
incubator or securely covered with black material or aluminum foil.
sample collection ● tIMInG 1 h, days 3–5
9. Collect 35 µl of supernatant from each well every 6 or 12 h into separate microtubes, starting right after changing the culture 
medium after transfection (considering the first samples as at 0 h). Spin the samples down at 200g for 5 min at room temperature to 
pellet cell debris, and transfer 30 µl of the supernatant to clean microtubes and store them at −20 °C.
 crItIcal step Before collecting the samples, gently shake the plate to provide uniform distribution of SEAP in the culture medium.
 pause poInt The supernatants can be stored at −20 °C for several months.
seap assay ● tIMInG 4 h, day 6
 crItIcal To detect the level of SEAP in the collected samples, we suggest using a Great EscAPe SEAP Fluorescence Detection Kit. All 
buffers described in the procedure below are from this kit.
10. Thaw the collected supernatants, and transfer 25 µl to individual wells of a 96-well plate.
11. Use a multichannel pipette to transfer 25 µl of 1× dilution buffer to each well, and then seal the plate with adhesive tape.
12. Incubate the sealed plate at 65 °C on a heat block or in a water bath for 30 min to inactivate endogenous phosphatases.
13. Cool the plate by placing it on ice for 2–3 min, and then centrifuge the plate at 1,200g for 3 min at room temperature.
14. Use a multichannel pipette to add 75 µl of assay buffer to each well, and incubate the buffer at room temperature for 5 min.
15. Prepare enough 120-µM 4-methylumbelliferyl phosphate (MUP) in 1× dilution buffer and use a multichannel pipette to add 25 µl of 
120-µM MUP solution to each well.
16. Seal the plate with transparent adhesive tape.
17. The excitation and emission peaks of MUP fluorescence are 360 nm and 449 nm, respectively; measure the MUP fluorescence  
for 2 h in 5-min intervals using a plate reader.
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Box 3 | Light activation of gene expression in mice ● tIMInG 10 h, over 5 d 
HeLa cells stably expressing BphP1–mCherry–TetR (Box 1) can be used for light-induced transcription activation after s.c.  
injection in mouse. For this, cells are cotransfected with the pCMV-104 plasmid, encoding the transcription activator VP16  
fused with NLS–PpsR2, and the pTRE-Tight-Rluc8 (7× tetO) reporter plasmid, encoding  
red-shifted Renilla luciferase (table 1). 24 h after transfection, 3 × 106 cells are s.c. injected into the interscapulum area  
of an FVB mouse. The efficiency of light-induced transcription activation is detected with an IVIS Spectrum instrument 48 h  
after injection.
procedure
culture of Hela cells ● tIMInG 1 h, day 1
1.Start with one 80% confluent 100-mm dish containing HeLa cells stably expressing BphP1–mCherry–TetR (Box 1) in DMEM media 
supplemented with 10% (vol/vol) FBS, 1% (vol/vol) penicillin–streptomycin and G418 active component (470 µg ml-1). For an experi-
ment on three illuminated animals and three dark-treated control animals, a total of 1.8 × 107 cells are required (3 × 106 cells per 
animal). To harvest the necessary amount of transfected HeLa cells, cotransfection with pCMV-104 and pTRE-Tight-Rluc8 plasmids (in 
steps 3–5) should be done on at least four 100-mm dishes (4 × 106 HeLa cells are expected to be harvested from a 100-mm dish after 
transfection).
2.  The day before transfection, seed 2 × 106 cells on each 100-mm dish in 10 ml of DMEM medium supplemented with 10% (vol/vol) 
FBS, 1% (vol/vol) penicillin–streptomycin and G418 active component (470 µg ml-1).
cotransfection procedure ● tIMInG 2 h, day 2
3. The next day, ensure that the cells are at high density (confluency ≥80%). To achieve higher transfection efficiency,  
we recommend using TransIT-LT1 transfection reagent as follows: warm the transfection reagent to room temperature and  
vortex gently before using. Place 6 ml of Opti-MEM medium in a sterile 15-ml tube. Add 15 µg of the plasmid DNA mix  
(pCMV-104 and pTRE-Tight-Rluc8 in a 5:1 ratio), and pipette gently to mix completely. Add 45 µl of the transfection  
reagent to the diluted DNA mixture. Pipette gently to mix completely, and incubate at room temperature for  
15–30 min.
4. While complex formation takes place, aspirate the medium from each dish with cells, wash the cells once with 10 ml of PBS and add 
15.5 ml of DMEM medium supplemented with 10% (vol/vol) FBS, 1% (vol/vol) penicillin–streptomycin and G418 active component 
(470 µg ml-1).
5. Add the DNA complexes dropwise to different areas of the dish. Gently rock the dish back and forth and from side to side to evenly 
distribute the DNA complexes. Transfer the dish to a tissue culture incubator and protect it from light.
preparation of animals for the experiment ● tIMInG 2 h, day 2
6. Before injection of the cells, the fur on the interscapular area of each mouse should be removed with a depilatory cream. To  
facilitate fur removal before applying the cream, fur may be cut away by using scissors or a shaving machine.
! cautIon Any experiments involving live mice must conform to relevant institutional and national regulations. All animal experiments 
in this protocol were performed in an AAALAC-approved facility according to permission no. 20160313 from the Albert Einstein College 
of Medicine Animal Use Committee.
Harvesting and injection of cells ● tIMInG 3 h, day 3
7. 24 h after transfection in step 5, trypsinize the cells from the culture dishes, transfer them to a 15-ml sterile tube,  
pellet the cells (180g, 4  °C, 7 min) and resuspend them in 10 ml of PBS without Ca2+ and Mg2+. Count the cells using  
a hemocytometer, pellet the cells by centrifugation at 180g for 7 min at 4 °C and resuspend them in 0.6 ml of RPMI-1640  
media without phenol red and with 2 mM l-glutamine to a final concentration of 3 × 107 ml−1. Transfer the cells to 0.5-ml  
syringes with a 28-gauge needle (3 × 106 cells in each syringe). Keep the syringes filled with cells on ice in the dark.
 crItIcal step During harvesting of transfected cells, do not expose them to bright sources of light.
8. Before injection of cells, anesthetize the mice with an isoflurane vaporizer. After s.c. injection, keep the animals under 740-nm light 
at 1 mW cm−2 or in the dark for 48 h.
! cautIon Be extremely cautious when handling isoflurane. The liquid is flammable and combustible, and the vapors are toxic.
Imaging of animals ● tIMInG 2 h, day 5
9. Before imaging, prepare the Rluc8 substrate. Dissolve Inject-A-Lume Coelenterazine native with sterile diluent  
to a final concentration of 2 mg ml-1 and prefill 0.5-ml syringes with a 28-gauge needle with 40 µl of the diluted  
substrate.
10. After 48 h, anesthetize the mice with an isoflurane vaporizer, and keep them under anesthesia throughout the  
imaging. Immediately before imaging, inject the mice i.v. through the retro-orbital vein with the Rluc8 substrate.  
Determine the efficiency of light-induced transcription activation by imaging the animals with an IVIS Spectrum in vivo  
imaging system.
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MaterIals
REAGENTS
HeLa cells (ATCC, cat. no. CCL-2)  crItIcal The cell lines should  
be regularly checked to ensure they are authentic and are not infected  
with mycoplasma.
DMSO (Fisher BioReagents, cat. no. BP231-100)
Trypsin EDTA (Corning, cat. no. 25-053-CI)
Penicillin–streptomycin (Corning, cat. no. 30-002-CI)
DMEM (GE Healthcare Life Sciences, cat. no. SH30022.02)
PBS (GE Healthcare Life Sciences, cat. no. SH30264.01)
PBS without Ca2+ and Mg2+ (GE Healthcare Life Sciences,  
cat. no. SH30256.01)
Biliverdin (BV; Frontier Scientific, cat. no. B655-9)
FBS (Gemini Bio-Products, cat. no. 100-106)
Effectene Transfection Reagent (Qiagen, cat. no. 301425)  
! cautIon The individual kit components may be harmful;  
check the safety data provided by the manufacturer.  
 crItIcal Transfection efficiency may greatly influence the  
results of the described protocols. Therefore, the transfection  
reagent should be carefully chosen.
Plasmid Maxi Prep Kit (Qiagen, cat. no. 12162)  
! cautIon The individual kit components may be  
harmful; check the safety data provided by the manufacturer.
Plasmid Midi Prep Kit NucleoBond Xtra Midi EF (Macherey-Nagel,  
cat. no. 740420.50) ! cautIon The individual kit components may be 
harmful; check the safety data provided by the manufacturer.
Live cell imaging solution (Life Technologies, cat. no. A14291DJ)
Bioluminescence assay reagent (NanoLight Technology, cat. no. 318)  
! cautIon The individual kit components may be harmful; check  
the safety data provided by the manufacturer.
Poly-l-lysine solution (0.01% (wt/vol); Merck, cat. no. A-005-C)
Tris-HCl (Thermo Fisher Scientific, cat. no. 15506017)
Glycerol (Thermo Fisher Scientific, cat. no. 17904)
β-mercaptoethanol (Thermo Fisher Scientific,  
cat. no. 21985023)
Triton X-100 (Thermo Fisher Scientific, cat. no. 85111)
PMSF (Thermo Fisher Scientific, cat. no. 36978)  
! cautIon This compound is toxic if swallowed. It causes severe  
skin burns and eye damage. Protect eyes and skin; do not inhale  
or swallow.
Plasmids (Table 1)
(Optional) Generation of a cell line stably expressing the BphP1  
component of the optogenetic system
G418 (Corning, cat. no. 61-234-RF; see Box 1)
Benzonase (Millipore Sigma, cat. no. 70746-4)
(Optional) Determination of the kinetics of light-induced transcription 
activation of the TetR-responsive system
Great EscAPe SEAP Fluorescence Detection Kit (Takara Bio,  
cat. no. 631704; see Box 2) ! cautIon The individual kit components  
may be harmful; check the safety data provided by the manufacturer.
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
FBS, tetracycline free (Takara Bio, cat. no. 631106)
(Optional) Light activation of gene expression in mice
2- to 3-month-old female FVB mice (20–25 g of body weight;  
see Box 3) (National Cancer Institute (NIH), strain no. 207)  
! cautIon Any experiments involving live mice must conform  
to relevant institutional and national regulations. All animal  
experiments in this protocol were performed in an AAALAC-approved 
facility according to permission no. 20160313 from the Albert  
Einstein College of Medicine Animal Use Committee.
TransIT-LT1 (Mirus Bio, cat. no. MIR 2304)
Opti-MEM (Gibco, cat. no. 31985062)
RPMI-1640 medium supplemented with l-glutamine (Gibco,  
cat. no. 11835030)
Inject-A-Lume Coelenterazine (NanoLight Technologies,  
cat. no. 303-INJ)
l-glutamine (Corning, cat. no. 25005CI)
EQUIPMENT
25-cm2 Culture flask (Corning, cat. no. 430639)
24-Well culture plate (Corning, cat. no. 3526)
Six-well culture plate (Corning, cat. no. 3516)
Inverted microscope (Olympus, model no. IX83 or a comparable  
epifluorescence microscope (see the Equipment Setup section))
NIR LED emitter (LED Engin, cat. no. LZ4-00R308)  
! cautIon If not adjusted properly, LED light sources  
may produce extremely bright light. Protect your eyes, if necessary.
Blue LED emitter (LED Engin, cat. no. LZ4-40B200)  
! cautIon If not adjusted properly, LED light sources  
may produce extremely bright light. Protect your eyes, if necessary.
Power source (Tekpower, cat. no. TP6005E)
24-gauge stranded wire (Remington Industries,  
cat. no. 24UL1007STRBLA)
Thermal adhesive tape (Luxeon Star LEDs, cat. no. LXT-S-12)
1-s–60-h pulse-pause timer (Velleman, cat. no. VM188)
NanoDrop ND-2000 spectrophotometer (Thermo Scientific,  
cat. no. ND2000USCAN)
Power meter (Thorlabs, cat. no. PM130D)
Power sensor (Thorlabs, cat. no. S130C)
Tissue culture hood (Thermo Fisher Scientific, 1300 Series A2 Biological 
Safety Cabinet) 
Tissue culture incubators, set to 37 °C, 5% CO2 (Forma Series 2; Thermo 
Fisher Scientific, cat. no. 3110)
Victor ×3 multilabel plate reader (PerkinElmer)
Hemocytometer (Hausser Scientific, cat. no. 3120)
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
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Figure 3 | Light-sensitivity of the iRIS optogenetic tool. Light-sensitivity 
of iRIS is determined by a combination of the absorption spectrum of 
the LOV domain in a ground state (dashed line) and by the previously 
measured light-action spectrum of BphP1 (solid line). The LOV part of 
iRIS can be activated with 460-nm light (light-blue box) without notable 
activation of the BphP1 part. The BphP1 part can be activated with NIR 
light of 730–790 nm (dark-red box). The dark-yellow box highlights the 
spectral region that is considered to be ‘safe’ in terms of a near-absence 
of iRIS light-activation. a.u., arbitrary units. Adapted from ref. 4, Nature 
Publishing Group.
Tridirectional targeting
Nucleus
NES signal CAAX signal QPAS1 BphP1 (Pr) mVenus mCherryAsLOV2NLS
Plasma membraneCytoplasm
BphP1–
mVenus–
CAAX
NLS is 
exposed
NES–
mCherry–
QPAS1–
AsLOV2NLS
460 nm 740 nm
Figure 2 | Mode of function of the light-controllable tridirectional 
subcellular targeting system. In the dark, the NES–mCherry–QPAS1–
AsLOV2NLS construct (iRIS) is localized in the cytoplasm and can be 
targeted to the nucleus or the plasma membrane with blue (460 nm) 
or NIR (740 nm) light, respectively. Blue light uncages the nuclear 
localization signal (NLS), which results in the iRIS translocation to the 
nucleus. NIR light converts the membrane-anchored BphP1 to the active 
Pr state and triggers its heterodimerization with QPAS1, which results 
in the iRIS translocation to the plasma membrane. Adapted from ref. 5, 
Nature Publishing Group. 
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35-mm cell culture dish (CELLview; Greiner Bio-One,  
cat. no. 627 860)
Cell chamber for microscopy (Thermo Fisher Scientific,  
cat. no. A7816)
Circle coverslips, 25 mm (Thermo Fisher Scientific,  
cat. no. 1014355125NR1)
96-Well half-area, white, flat-bottom plates (Corning,  
cat. no. 3693)
Centrifuge with a holder for 96-well plates
200-W metal-halide arc lamp (Lumen, model no. 220PRO)
40× or 60× objective lens (e.g., Olympus UPlanSApo 40×, 0.95-NA  
(numerical aperture) air or 60×, 1.35-NA oil lens)
Scientific complementary metal oxide semiconductor (sCMOS) camera 
(e.g., QImaging optiMOS camera)
OriginPro v8.6 graphing and data-analysis software  
(https://www.originlab.com/)
ImageJ v1.51J8 image analysis software (https://imagej.nih.gov/ij/)
Fiji v1.50b image analysis software (https://fiji.sc/)
(Optional) Generation of a cell line stably expressing the BphP1  
component of the optogenetic system
150-mm Culture dish (Corning, cat. no. 430599; see Box 1)
100-mm Culture dish (Corning, cat. no. 430167)
60-mm Culture dish (Corning, cat. no. 430166)
FACS tube (Corning, cat. no. 352063)
30-µm Filter (Sysmex, cat. no. 04-004-2336)
15-ml Sterile centrifuge tube (Corning, cat. no. 430790)
(Optional) Determination of the kinetics of light-induced transcription 
activation of the TetR-responsive system
12-Well culture plate (Corning, cat. no. 3513; see Box 2)
96-Well black plate (Greiner Bio-One, cat. no. 655076)
SpectraMax M2 fluorescence plate reader  
(Molecular Devices)
(Optional) Light-activation of gene expression in mice
0.5-ml Syringe (BD, cat. no. 329461; see Box 3)
IVIS Spectrum in vivo imaging system (Perkin Elmer,  
cat. no. 124262)
REAGENT SETUP
MidiPrep plasmid DNA purification The purity of plasmid DNA and  
the absence of endotoxins are critical for transfection efficiency. Use the 
NucleoBond Xtra Midi EF plasmid purification kit or similar to ensure a 
pure, endotoxin-free plasmid DNA sample. Purified plasmid can be stored  
at −20 °C for several months.
Lysis buffer (for bioluminescence assay) Lysis buffer is 20 mM Tris-HCl, 
pH 8.0, 10% (vol/vol) glycerol, 0.1% (vol/vol) β-mercaptoethanol, 0.1% 
(vol/vol) Triton X-100 and 1 mM PMSF. Make fresh lysis buffer before  
each experiment.
BV stock solution Prepare a 100 mM BV stock solution in DMSO (this can 
be stored at 4 °C for up to 6 months). Add the BV stock to the cell culture 
medium >6 h before the medium change to ensure it completely dissolves.  
Do not add the transfection reagent in culture medium containing BV.  
BV is rather stable in the culture medium, so BV-containing medium  
may be stored for several days at +4 °C.
Poly-l-lysine-coated tissue culture dishes or coverslips Prepare  
0.1 mg ml–1 poly-l-lysine solution in sterile water. Fully cover the  
surface of the cell culture dish or coverslip. Incubate the solution  
for 1–12 h at room temperature (20–25 °C). Aspirate the poly- 
l-lysine solution and wash the vessel with sterile water. Allow  
the surface to dry aseptically. Coated vessels can be stored at  
room temperature for at least several weeks.
EQUIPMENT SETUP 
Safelight Preferably, to prevent activation of optogenetic systems by  
ambient light, a tissue culture hood should be located in a darkroom.  
If no darkroom is available, cover sources of light, such as windows or  
doors, with black adhesive vinyl foil or aluminum foil. The tissue culture 
room can be equipped with a source of orange safelight (Fig. 3). For this,  
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
an LED strip or LED bulb emitting light at 550–600 nm may be mounted 
outside the hood.
LED arrays For illumination of the cells, we designed and used maximally 
simplified equipment that does not require special skills and that can be  
assembled in a fast and a cost-effective way (Fig. 4). LEDs of one  
wavelength for the illumination of tissue culture plates may be mounted on 
the CPU heat sink. For example, we used a CPU heat sink with a mounting 
surface area of 60 mm ×y 70 mm. This heat sink accommodates an array 
consisting of nine LEDs, each 20 mm in diameter. LEDs are mounted on 
the heat sink with a thermal adhesive tape. All LEDs are connected by a 
parallel circuit assembly of three rows, each containing three LEDs. LEDs 
may be connected to a standard power supply. However, to provide  
regulation of light flux, the power supply should have adjustable voltage 
and current. The light power should be measured by the optical power 
meter. The pulse regimen of the illumination can be provided by a  
pulse-pause timer serially connected between the LED and the power  
supply. With the pulse-pause timer, ON and OFF steps can be easily  
adjusted from 1 s to several hours. A support stand with a rod and a  
wire support with a clamp can be used to hold the LED array above the 
culture plate to provide even illumination of wells. Light flux power levels 
used for activation of optogenetic systems are low enough to avoid the need 
for special measures directed to LED cooling. The passive dissipation of 
heat provided by the CPU heat sink is sufficient for the vast majority of  
experiments. If overheating occurs, a fan may be added to the heat  
sink to increase heat dissipation.
Microscopy setup Epifluorescence microscopy can be performed  
with an inverted microscope. A 200-W metal-halide arc lamp can  
be used for both imaging and activation through the objective,  
using appropriate filter sets. If activation through the objective is  
used, check the cutoff wavelength of the IR filter, if installed in a  
light source to prevent sample overheating, and consider replacing  
or removing it if the filter does not transmit light within the 700-  
to 800-nm range. Measure the activation light power density at a  
back focal plane of the objective lens. Alternatively, LED arrays  
may be used as a source of activation light. For this, install the  
arrays instead of the transmitted light source to illuminate the  
sample from the top, and measure the light intensity at the  
sample plane. Perform image acquisition using a 40× or 60×  
objective lens and a sCMOS camera. Do not use the automatic  
autofocusing systems, which exploit NIR light for measurements  
of the distance to the sample; check the technical specification  
of the microscope for details.
Power
source
d.c.
–
+
Pulse-pause
timer
LED
array
a b
Figure 4 | Setup for the LED illumination. (a) The connection  
scheme of the major components is shown. Nine LEDs mounted  
on a CPU heat sink and connected by a parallel circuit of three  
rows with three LEDs each make up the LED array. To provide a  
pulsed regimen of illumination, the pulse-pause timer is serially 
connected between the LED array and the power source.  
(b) Photograph of the assembled setup.
© 
20
18
 N
at
u
re
 A
m
er
ic
a,
 In
c.
, p
ar
t 
o
f 
S
p
ri
n
g
er
 N
at
u
re
. A
ll 
ri
g
h
ts
 r
es
er
ve
d
.
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
protocol
1130 | VOL.13 NO.5 | 2018 | nature protocols
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
proceDure
culture of Hela cells ● tIMInG 1 h, afternoon of day 1
1| Culture a sufficient amount of healthy HeLa cells in DMEM medium supplemented with 10% (vol/vol) FBS and  
1% (vol/vol) penicillin–streptomycin to ensure the appropriate transfection efficiency.
 crItIcal step Deteriorated culture is often the cause of excessive toxic effects of the transfection reagent or other  
undesired effects. Consistency of the subculture schedule is a key to ensuring reproducible results.
2| Dissociate the cells using 1× trypsin–EDTA solution when subconfluent and seed the cells in a 24-well plate to obtain  
~80% confluency after overnight cultivation (~1.5 × 105 cells per well). Prepare wells in triplicate for each experimental  
condition (NIR light, blue light and dark) and for controls. Typically, for transcription activation, at least nontransfected 
cells and cells transfected with reporter vector and mock plasmid (instead of the light-controlled construct) are used as  
controls. For estimation of the absolute expression level, cells may be transfected with the transcription activator without  
a light-sensing component such as Gal4-VP16. Choose additional controls specific to your study, if needed.
transfection procedure ● tIMInG 2 h, day 2
3| To prepare the DNA mix for transcriptional activation and bioluminescence assay, follow option A, and for tridirectional 
subcellular targeting, follow option B (table 1).
(a) Dna mix for transcriptional activation and bioluminescence assay
 (i)  Prepare 200 ng of the following plasmid DNA mix (all the reagent amounts at this step are indicated per well of a 
24-well plate):
tube plasmid amount
T2A pQP-T2A  
pFR-Luc
150 ng  
50 ng
GAVPO pGAVPO  
pFR-Luc
100 ng  
100 nga
Control T2A ‘Blank’ plasmid  
pFR-Luc
150 ng  
50 ng
Control GAVPO ‘Blank’ plasmid  
pFR-Luc
100 ng  
100 nga
aPlasmid ratio according to ref. 3.
 crItIcal step All mixes should be prepared in a volume sufficient for transfection of cells for three illumination  
conditions: 740 nm, 460 nm and in the dark, all wells in triplicate.
 crItIcal step To avoid toxic effects after transfection, use endotoxin-free quality plasmid DNA purification kits  
(Reagent Setup).
 (ii)  Increase the volume to 60 µl using DNA-condensation buffer. Add 1.6 µl of enhancer and mix by vortexing for 1 s. 
Incubate at room temperature for 2–5 min.
(B) Dna for tridirectional subcellular targeting
 (i)  Prepare 200 ng of the pQP-iRIS plasmid DNA (all the reagent amounts at this step are indicated per well of a  
24-well plate). 
 crItIcal step To avoid toxic effects after transfection, use endotoxin-free quality plasmid DNA purification  
kits (Reagent Setup).
 (ii)  Increase the volume to 60 µl using DNA-condensation buffer. Add 1.6 µl of enhancer and mix by vortexing for  
1 s. Incubate at room temperature for 2–5 min.
4| Add 5 µl of Effectene transfection reagent to the DNA-enhancer mixture. Mix the samples by vortexing for 10 s.  
Incubate the samples for 5 min at room temperature for transfection-complex formation.
5| Add DMEM medium supplemented with 10% (vol/vol) FBS and 1% (vol/vol) penicillin–streptomycin to the tube  
containing the transfection complexes to a final volume of 400 µl and mix by pipetting. Aspirate the medium from the  
24-well plates, wash once with warm PBS buffer and add the medium with transfection mixes to the cells. Gently shake the 
plate to ensure uniform distribution of the transfection complexes. Incubate the plate for 6 h under normal growth conditions.
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6| Aspirate the medium containing the transfection complexes. Wash the cells once with 1–2 ml of prewarmed PBS buffer. 
Add 0.5 ml of fresh DMEM medium supplemented with 10% (vol/vol) FBS and 1% (vol/vol) penicillin–streptomycin, and also 
supplemented with 25 µM BV (for protocol setup without exogenous BV addition, see Box 1). Place the cells back into the 
incubator for another 42 h when performing the transcription activation and bioluminescence assay (Step 7A), or for 18 h 
when performing the tridirectional subcellular localization assay (Step 7B).
 crItIcal step Although the Effectene transfection reagent may be kept on cells longer than 6 h for most applications, 
it is not recommended to add BV-containing media to the cells simultaneously with the transfection complexes, as this may 
lead to inappropriate BV uptake or even cause cytotoxicity.
Illumination and analysis of results
7| Depending on the experimental setup and plasmids used in Step 3, use option A for bioluminescence assay or option B 
for tridirectional subcellular targeting.
(a) transcription activation and bioluminescence assay ● tIMInG 3.5 h, days 3–5
 (i)  Turn on the 740-nm (alternating cycles of 30 s of light and 180 s of dark) and 460-nm (continuous) illumination 
(recommended intensity: 1 mW cm−2) in separate cell culture CO2 incubators or well isolated from one another.  
Samples transfected with ‘T2A’ and ‘GAVPO’ mixes (see Step 3A) should be illuminated with both 740-nm and  
460-nm light separately, so that each illumination condition contains both optogenetic systems for comparison. 
Keep the dark samples (again both ‘T2A’ and ‘GAVPO’) in a separate CO2 incubator or securely covered with black 
material or aluminum foil. Control plates can be placed into either an illuminated or dark incubator, as no  
phototoxicity is expected at the indicated light intensities. Illuminate the cells under normal growth conditions  
42 h after the removal of Effectene transfection reagent (Step 6). 
 crItIcal step When arranging the illumination, check for overheating of LED array heat sinks. Monitor  
the temperature in the CO2 incubator and water condensation on the plate covers due to excessive warming.  
If overheating occurs, improve the ventilation (add more space between the arrays and CO2 incubator surfaces)  
or reduce light intensity (740-nm light intensity, as measured on a plate surface, may be reduced to 0.2 mW cm−2 
without a noticeable change in transcription activation levels). In addition, separate incubators may be used for  
NIR and blue light. Pulse illumination regimens help to avoid the overheating.
 (ii)  Wash the cells with 1 ml of PBS. Add 100 µl of freshly prepared ice-cold lysis buffer (see the Reagent Setup section) 
to each well. 
! cautIon Work under a hood while using appropriate protection to avoid PMSF inhalation or contact with skin.
 (iii)  Incubate the cells on a gently agitating platform at 4 °C for 30 min to lyse the cells.
 (iv)  Transfer 10 µl of cell lysate from each well to a 96-well half-area nontransparent plate.
 (v)  Add 20 µl of Bioluminescence assay reagent to each well, using a multichannel pipette or a luminometer injector.  
Measure bioluminescence using a luminometer. 
? trouBlesHootInG
(B) tridirectional subcellular targeting in single cells ● tIMInG 6 h, days 3–5
 (i)  Incubate the cells in the dark for 18 h after the medium change after the transfection (Step 6). Wash the cells  
with 1 ml of PBS and dissociate the cells using 1× trypsin−EDTA solution.
 (ii)  Seed the cells transfected with pQP-iRIS from Step 6 (4 × 105 to 8 × 105 cells per vessel) in  glass-bottom tissue 
culture dishes (CELLview or similar, see the EQUIPMENT section) or coverslips precoated with poly-l-lysine (Reagent 
Setup) for better attachment. Incubate the cells under normal growth conditions for 3–24 h to allow them to attach. 
 crItIcal step The incubation step is to ensure a low-density culture of healthy attached cells appropriate  
for imaging. The duration of incubation depends on the particular cell type and cell culture vessel used, and  
can also be affected by the expression level of the proteins to be imaged. During the incubation, avoid intensive  
illumination by avoiding routinely examining the cells under the microscope.
 (iii)  Gently aspirate the medium and wash the cells with 3 ml of warm PBS. Be careful if you use nonadherent cells  
instead of HeLa cells. When using glass coverslips in Step 7B(ii), mount the coverslips into a cell chamber for  
microscopy according to the chamber manufacturer’s recommendations. Ensure the absence of leakage. Add 37 °C  
live cell imaging solution, 1–2 ml to the coverglass chamber or 2–3 ml to the glass-bottom tissue culture dish. 
 crItIcal step The maximum incubation time for incubating cells in live cell imaging solution without altering 
the cell physiology is limited to 2–4 h, depending on cell culture and the illumination scheme. Incubation for  
too long in live cell imaging solution followed by an imaging session may influence cell viability. Therefore, it  
is recommended to prepare a single dish before each imaging session, avoiding the simultaneous preparation of  
dish series. 
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 crItIcal step Cells may be imaged at a different confluence or in a different medium, if this is required by  
the specific protein of interest or experimental design.
 (iv)  Place the glass-bottom dish or cover glass chamber into the stage holder. Ensure an even temperature in the live  
cell imaging chamber, to eliminate thermal drift during the time lapse.
 (v)  Determine the appropriate imaging parameters, allowing sufficient signal-to-noise ratio for the ‘red’ mCherry channel 
(excitation: 560/25 nm; emission: 607/36 nm). Check for proper target protein localization at the initial stage in 
the dark and acquire an image. 
 crItIcal step At this point, exposure to blue excitation light in the ‘green’ channel (excitation: 485/20 nm; 
emission: 525/30 nm) should be avoided, to prevent unwanted activation of the LOV-based component of the iRIS. 
Focusing and target protein observation should be performed using mCherry fluorescence. 
 crItIcal step During the time lapse, the focal plane may be lost due to thermal drift (Step 7B(iv)) or  
the cells’ natural motility. Therefore, z-stack acquisition is recommended to ensure appropriate focusing during  
time-lapse imaging. 
 crItIcal step Protocols for epifluorescence imaging are microscope-dependent, and here we provide general 
guidelines for image acquisition. All of the acquisition steps are described for an Olympus IX83 microscope;  
however, similar functions should be readily available on most inverted epifluorescence microscopes. Please  
consider the manufacturer’s instructions for your particular instrument and read the Equipment Setup section.
 (vi)  Determine an appropriate frame rate for the analysis of the target protein relocalization kinetics. We  
recommend starting from 2 frames per min for the activation of the iRIS (both blue and NIR) and 1 frame  
per 4 min for the recovery. 
 crItIcal step Practically, the target protein relocalization time depends on the fusion partner’s physical  
properties, the protein diffusion rate in the cytoplasm and the nuclear transport rates (if active nuclear transport  
is involved). For best performance, pilot trials should be performed to find an optimal frame rate.
 (vii)  Turn on the 460-nm illumination (recommended intensity: 1 mW cm−2) (see the Equipment Setup section for  
the description of the illumination setup through the objective lens or using a LED array; also check the  
recommendations for correct light intensity measurements for both illumination options) and perform  
time-lapse imaging for relocalization from the cytoplasm to the nucleus.
 (viii)  Keep the cells in the dark for 30 min in order to allow LOV-domain thermal relaxation. Check the reporter protein  
for cytoplasmic localization using the mCherry channel. Perform imaging in the mCherry channel during the incuba-
tion time in the dark, if needed.
 (ix)  Adjust the frame rate for the analysis of the kinetics of target protein relocalization from the cytoplasm to the 
plasma membrane, turn on the 740-nm illumination (recommended intensity: 1 mW cm−2) and perform time-lapse 
imaging. Avoid exposure to blue light (excitation: 485/20 nm; emission: 525/30 nm) to prevent activation of the 
LOV-based component of iRIS. 
 crItIcal step Because the kinetics for the relocalization to the membrane may differ from the kinetics of  
relocalization to the nucleus, adjust the frame rate appropriately. The frame rate for the relocalization to the  
membrane may be between 2 and 12 frames per min.
 (x)  Keep the cells in the dark for 30 min in order to allow BphP1 thermal relaxation and QPAS1 dissociation.  
Perform imaging in the mCherry channel during the incubation time in the dark, if needed. The relaxation  
process may be facilitated by exposure to 620-nm light. 1 mW cm−2 of 620-nm illumination results in  
doubling of the relaxation rate.
 (xi)  Export the images in an uncompressed format suitable for quantitative analysis. Ensure that the images  
were not automatically corrected in any way, leading to intensity distribution changes. 
 crItIcal step The procedure details are software dependent but may be performed by using almost any  
software for operating fluorescence microscopes or by using open-source software for image analysis, such  
as ImageJ43,44.
 (xii)  Subtract the background fluorescence from the captured images.
 (xiii)  Make a stack from time points and align the images within the stack using rigid body registration or a similar  
algorithm to reduce misalignment due to cell motility. Choose an appropriate number of regions of interest  
(ROIs) in the cytoplasm and/or nucleus.
 (xiv)  Perform analysis of the captured images. Analyze the kinetics of fluorescence intensity in the respective  
compartments. For each time point, normalize the intensity level to the average fluorescence for the whole  
cell, to account for photobleaching due to exposure during time-lapse imaging. 
? trouBlesHootInG
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Troubleshooting advice can be found in table 2.
● tIMInG
Steps 1 and 2, culture of HeLa cells: 1 h (day 1)
Steps 3–6, transfection procedure: 2 h (day 2)
Step 7A(i), transcription activation: 1.5 h (days 3–5)
Step 7A(ii–v), bioluminescence assay: 2 h (days 3–5)
Step 7B(i,ii), preparation of cells for tridirectional subcellular targeting: 2 h (days 3–5)
Step 7B(iii–x) tridirectional subcellular targeting in single cells: 3 h (days 3–5)
Step 7B(xi–xiv) export of results and data analysis: 1 h (days 3–5)
Box 1, generation of a cell line stably expressing the BphP1 component of the optogenetic system: 6 weeks
Box 2, determination of the kinetics of light-induced transcription activation using a TetR-responsive system: 12 h, over 6 days
Box 3, light-activation of gene expression in mice: 10 h, over 5 days
taBle 2 | Troubleshooting table.
step problem possible reason solution
7A(v) High background level of 
transcription in the dark
QPAS1 or PpsR2 binding by 
BphP1 apoprotein due to  
insufficient endogenous BV  
concentration
Consider one of the following options:  
•   Add BV to the cell culture medium or increase its  
concentration. Most cell lines are tolerant to BV  
concentrations up to 25 µM 
•  Use a cell line stably expressing BphP1 (Box 1)
Expression level of transcription 
activation system components 
is too high
The easiest solution is to reduce the amount of  
plasmids used in the transfection procedure (Step 3),  
either by using mock plasmid as a substitute, or by  
adjusting the activator/reporter plasmid ratio  
Alternatively, the following modifications may be performed: 
•  Use weaker promoters (may depend on the particular cell 
line), e.g., CMVd1 (Promega) 
•  Use an internal ribosome entry site (IRES) of different  
efficiency, or use a self-cleaving peptide sequence to 
adjust the expression levels of system components46,47. 
•  Try different transfection reagents or alternative  
gene-delivery options that are suitable for the particular 
experiment
7B(xiv) High background level 
of plasma membrane–
bound iRIS in the dark 
or under 460-nm light 
(supplementary Fig. 5a)
QPAS1 binding by BphP1  
apoprotein due to low  
endogenous BV concentration, 
or iRIS expression is too high
See troubleshooting advice for Step 7A(v).  
•  Reduction of the expression level of the iRIS may help.  
Try to reduce the intensity of 460-nm light, and reduce 
exposure to ambient illumination
Shifted cytoplasm–nucleus 
equilibrium of iRIS localiza-
tion (e.g., high background 
in the nucleus under  
740-nm light) 
(supplementary Fig. 5b)
Nuclear transport machinery  
performance may differ in  
certain model organisms  
or cell lines48
The system may be modified using nuclear localization or 
nuclear exclusion signals of variable strength28,38–40. Avoid 
exposure to blue light or ambient illumination
Low mCherry fluorescence 
signal from the iRIS after 
time-course imaging
Photobleaching Reduce the exposure to excitation light (excitation: 485/20 
nm or excitation: 560/25 nm) by using neutral-density filters. 
Alternatively, choose a lower frame rate for image acquisition, 
or capture fewer z-sections for each time point
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antIcIpateD results
Gene transcription activation (step 7a)
This PROCEDURE results in the expression of a target gene  
in the 740-nm illuminated cells, demonstrating a rather  
low background activation in the dark. Typically, the  
signal level in the illuminated samples differs from that  
of those kept in the dark by a factor of 35–40 for both  
the bioluminescence and the SEAP reporter assays (Fig. 5,  
supplementary Fig. 2). The absolute signal level is  
comparable to that obtained by activation with the  
nonconditional transcription activators based on the  
VP16 transactivation domain. Importantly, the increase  
in target protein expression level in cells expressing the  
BphP1-based system following exposure to 460-nm light  
is negligible (Fig. 5), which makes the BphP1–QPAS1 pair  
an optogenetic system of choice for spectral multiplexing  
with numerous blue-light-activatable tools.
A 35-fold light-to-dark contrast of SEAP production  
can be achieved using mammalian cells stably expressing  
BphP1, without any supply of exogenous BV (Boxes 1–3).  
The SEAP accumulation curve typically has a sigmoid shape and reaches its plateau after 36 h (supplementary Fig. 2b).  
A 32-fold increase in bioluminescence, caused by light-controlled transcription activation, may be achieved in the s.c.  
injected cells stably expressing BphP1 when illuminated in living mice (supplementary Fig. 3)
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Figure 5 | Spectral compatibility of the BphP1–QPAS1 and blue-light-
activatable transcription systems. Light-to-dark ratios of luciferase reporter 
were detected in HeLa cells transfected with either LightOn or BphP1–QPAS1 
transcription activation systems. Samples were illuminated either with 
continuous 460-nm light of 1 mW cm−2 or 740-nm pulsing light (30 s ON, 
180 s OFF) of 1 mW cm−2. The results of individual experiments are shown as 
dots; bars represent the respective mean values; error bars are s.e.m.;  
n = 3. Adapted from ref. 5, Nature Publishing Group. 
t = 16 mint = 12 mint = 8 mint = 4 mint = 0 min
t = 20 min t = 24 min
 t = 28 min t = 32 min t = 36 min
Cy
to
pl
as
m
flu
or
es
ce
nc
e 
(a.
u.)
0
0.2
0.4
0.6
0.8
1
0 10 70 80 140
74
0 
nm
46
0 
nm
 
D
ar
kn
es
s
Time (min)
D
ar
kn
es
s
1 2
3
4
5
ROI
460 nm, 10 minDarkness Darkness, 60 min Darkness, 60 min740 nm, 10 min
ba
c d
0
0.2
0.4
0.6
0.8
0 168 24 32 40
Time (min)
Cy
to
pl
as
m
flu
or
es
ce
nc
e 
(a.
u.) 1.0
1.2e
Figure 6 | Two-color light-controlled tridirectional intracellular protein targeting. (a) Sequential targeting of iRIS from the cytoplasm to the nucleus and to 
the plasma membrane in a single cell after the indicated illumination periods: after 10 min of 460 nm of 1 mW cm−2 illumination, after 60 min in darkness, 
after 10 min of 740 nm of 1 mW cm−2 illumination and after 60 min in darkness again. All images were acquired at 37 °C using an epifluorescence microscope. 
(b) mCherry fluorescence of iRIS in cells illuminated as shown in a. Error bars represent s.e.m., n = 10 cells for each bar. (c) mCherry-tagged protein 
dissociation from the plasma membrane in the dark due to BphP1 thermal relaxation (time-lapse imaging). (d) Example of region of interest (ROI) placement  
for quantification of cytoplasmic fluorescence. (e) mCherry fluorescence of iRIS measured in the cytoplasm of HeLa cells pre-illuminated with 740-nm light  
and subsequently kept in the dark (black line) or under 620-nm illumination (red line). The 1-min pulses of 620-nm light (1 mW cm−2) were alternated with  
1 min of darkness. Epifluorescence images of cells were acquired every 4 min. The observed dissociation half-time was ~4.4 min in the dark and ~2.3 min  
under 620-nm illumination. Fitting of the exponential curve was performed using OriginPro 8.6. Error bars represent s.e.m., n = 10 cells similar to those  
shown in c for each time point. Scale bars, 10 µm (apply to d as well). a,b,e adapted from ref. 5, Nature Publishing Group.
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tridirectional targeting in single cells (step 7B)
The iRIS tool enables the light-controllable translocation of a target protein between the cytoplasm, the nucleus and the 
plasma membrane in single cells (Fig. 6a, supplementary Figs. 4 and 5). The relocalization of the target protein fused  
with a fluorescent tag to the nucleus is observed in response to 460-nm light. The fluorescence level in the nucleus reaches 
its maximum after ~20 min of blue-light illumination. In the dark, the target protein returns to the cytoplasm, and it  
can subsequently be recruited to the plasma membrane with 740-nm light. After translocation to the plasma membrane,  
fluorescence of the target protein’s mCherry tag can be visualized by creating an intensity profile (supplementary Fig. 4),  
in which the cell perimeter and the filopodia appear as sharp peaks. Quantification of fluorescence at the plasma membrane 
can be problematic; therefore, the fluorescence decrease in the cytoplasm is recommended as a quantity to measure for  
characterization of the kinetics and degree of protein relocalization. When using an epifluorescence microscope without  
optical sectioning, the typical decrease of cytoplasmic fluorescence due to the targeting to the nucleus or to the plasma 
membrane is 40% (Fig. 6b). The light-induced relocalization of the target protein from the cytoplasm is rather quick  
(1–5 min) and fully reversible (Fig. 6b–e). A half-life for the thermal relaxation of the BphP1–QPAS1 system, resulting in  
returning the protein to the cytoplasm, is ~4.4 min in the dark; this can be reduced to ~2.3 min with 620-nm  
illumination (Fig. 6e).
Further information on experimental design is available in the life sciences reporting summary.
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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?    Experimental design
1.   Sample size
Describe how sample size was determined. For bioluminescence and SEAP analyses all cells from a well of the 24-well or 12-
well plate were analyzed. All experiments were repeated 3 times.  (n = 3).  
For quantification of mCherry fluorescence signal upon near-infrared and blue light 
illumination in microscopy 10 cells were analyzed (n = 10) 
Both experimental and control mice groups contained 3 animals (n = 3)  
2.   Data exclusions
Describe any data exclusions. No sample was excluded from data analysis
3.   Replication
Describe whether the experimental findings were 
reliably reproduced.
The experiments were reliably reproduced. All experiments were performed at 
least 3 times. 
4.   Randomization
Describe how samples/organisms/participants were 
allocated into experimental groups.
Randomization method was not applied
5.   Blinding
Describe whether the investigators were blinded to 
group allocation during data collection and/or analysis.
No blinding was employed.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
6.   Statistical parameters 
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the 
Methods section if additional space is needed). 
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same 
sample was measured repeatedly
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one- or two-sided (note: only common tests should be described solely by name; more 
complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
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?   Software
Policy information about availability of computer code
7. Software
Describe the software used to analyze the data in this 
study. 
Data were analyzed using OriginPro 8, and images were analyzed using ImageJ 
1.50i software. No custom algorithms were used
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made 
available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for 
providing algorithms and software for publication provides further information on this topic.
?   Materials and reagents
Policy information about availability of materials
8.   Materials availability
Indicate whether there are restrictions on availability of 
unique materials or if these materials are only available 
for distribution by a for-profit company.
The nucleotide and amino acid sequences of the proteins used in the manuscript 
are already available in public repositories; 
All major plasmids, their maps and their sequences, generated in this manuscript, 
will be available via Addgene nonprofit public depository.
9.   Antibodies
Describe the antibodies used and how they were validated 
for use in the system under study (i.e. assay and species).
No antibodies were used
10. Eukaryotic cell lines
a.  State the source of each eukaryotic cell line used. HeLa cell line were purchased from ATCC (CCL2)
b.  Describe the method of cell line authentication used. Cell lines were purchased from ATCC and were not additionally authenticated
c.  Report whether the cell lines were tested for 
mycoplasma contamination.
Cell line was not tested for mycoplasma contamination
d.  If any of the cell lines used are listed in the database 
of commonly misidentified cell lines maintained by 
ICLAC, provide a scientific rationale for their use.
No commonly misidentified cell lines were used
?    Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
11. Description of research animals
Provide details on animals and/or animal-derived 
materials used in the study.
The FVB 2-3 month old female mice (NCI/NIH, USA) of 20-25 g body weight were 
used for in vivo light-induced transcription activation
Policy information about studies involving human research participants
12. Description of human research participants
Describe the covariate-relevant population 
characteristics of the human research participants.
This study did not involve human research participants
Nature Protocols: doi:10.1038/nprot.2018.022
